Total Payments
$11,640
2024 Payments
$1,974
Companies
51
Transactions
872
Medicare Patients
2,512
Medicare Billing
$160,689
Payment Breakdown by Category
Food & Beverage$11,565 (99.4%)
Education$74.99 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,565 | 861 | 99.4% |
| Education | $74.99 | 11 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,583 | 62 | $0 (2024) |
| Novo Nordisk Inc | $1,344 | 146 | $0 (2024) |
| Lilly USA, LLC | $1,267 | 97 | $0 (2024) |
| ABBVIE INC. | $1,015 | 81 | $0 (2024) |
| Amgen Inc. | $809.89 | 51 | $0 (2024) |
| PFIZER INC. | $790.61 | 84 | $0 (2024) |
| Merck Sharp & Dohme LLC | $418.76 | 35 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $296.54 | 14 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $294.03 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $290.92 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,974 | 112 | AstraZeneca Pharmaceuticals LP ($373.72) |
| 2023 | $1,787 | 119 | AbbVie Inc. ($357.60) |
| 2022 | $1,605 | 106 | ABBVIE INC. ($227.11) |
| 2021 | $1,374 | 109 | Lilly USA, LLC ($191.52) |
| 2020 | $1,324 | 99 | AstraZeneca Pharmaceuticals LP ($244.19) |
| 2019 | $991.34 | 85 | PFIZER INC. ($230.31) |
| 2018 | $996.15 | 97 | Novo Nordisk Inc ($155.45) |
| 2017 | $1,590 | 145 | AstraZeneca Pharmaceuticals LP ($288.61) |
All Payment Transactions
872 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $33.19 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Oncology | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.34 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Bone Health | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | ROTATEQ (Biological), VAXNEUVANCE, VAXELIS | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: VACCINE | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Obesity | ||||||
| 09/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: PAIN | ||||||
| 08/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 322 | 494 | $67,417 | $14,164 |
| 2020 | 31 | 2,190 | 4,014 | $476,429 | $146,526 |
Total Patients
2,512
Total Services
4,508
Medicare Billing
$160,689
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 101 | 112 | $24,192 | $4,053 | 16.8% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 31 | 127 | $14,224 | $3,041 | 21.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $5,560 | $2,386 | 42.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 75 | $10,950 | $2,267 | 20.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 22 | 38 | $6,574 | $1,763 | 26.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 14 | 14 | $1,762 | $280.47 | 15.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 22 | $1,914 | $211.35 | 11.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 19 | 28 | $1,652 | $116.71 | 7.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 20 | 21 | $441.00 | $45.00 | 10.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 12 | 37 | $148.00 | $0.99 | 0.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 318 | 868 | $126,728 | $39,288 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 319 | 586 | $126,576 | $38,998 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 188 | 188 | $52,264 | $20,492 | 39.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 163 | 213 | $18,531 | $5,686 | 30.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 34 | 34 | $14,280 | $5,521 | 38.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 36 | 36 | $7,200 | $4,235 | 58.8% |
| 17000 | Destruction of skin growth | Office | 2020 | 70 | 98 | $15,484 | $3,998 | 25.8% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2020 | 25 | 149 | $16,688 | $3,681 | 22.1% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 158 | 165 | $5,280 | $3,099 | 58.7% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 71 | 96 | $12,384 | $2,775 | 22.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 168 | 176 | $5,984 | $2,726 | 45.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 26 | 38 | $6,574 | $2,078 | 31.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 11 | 11 | $6,248 | $2,026 | 32.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 80 | 221 | $13,039 | $1,839 | 14.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 13 | 13 | $5,226 | $1,813 | 34.7% |
About Dr. Philip Stitzer, DO
Dr. Philip Stitzer, DO is a Family Medicine healthcare provider based in Moberly, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881693323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Stitzer, DO has received a total of $11,640 in payments from pharmaceutical and medical device companies, with $1,974 received in 2024. These payments were reported across 872 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($11,565).
As a Medicare-enrolled provider, Stitzer has provided services to 2,512 Medicare beneficiaries, totaling 4,508 services with total Medicare billing of $160,689. Data is available for 2 years (2020–2021), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Moberly, MO
- Active Since 07/18/2005
- Last Updated 04/22/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881693323
Products in Payments
- FARXIGA (Drug) $964.16
- VRAYLAR (Drug) $564.26
- JARDIANCE (Drug) $523.67
- Ozempic (Drug) $503.78
- REXULTI (Drug) $418.87
- MOUNJARO (Drug) $392.80
- BREZTRI (Drug) $361.99
- ZENPEP (Drug) $333.18
- UBRELVY (Drug) $315.24
- Otezla (Drug) $269.24
- Rybelsus (Drug) $257.51
- Tresiba (Drug) $243.76
- LYRICA (Drug) $243.52
- EVENITY (Biological) $215.33
- BASAGLAR (Drug) $213.90
- Victoza (Drug) $206.92
- XARELTO (Drug) $200.69
- ENTRESTO (Drug) $190.07
- TRULICITY (Drug) $175.52
- QULIPTA (Drug) $169.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Moberly
Jon Rampton, Do, DO
Family Medicine — Payments: $12,827
Family Medicine $12,827
Forest Conley, Do, DO
Family Medicine — Payments: $8,967
Family Medicine $8,967
Dr. Heather Gessling, Md, MD
Family Medicine — Payments: $8,817
Family Medicine $8,817
Dr. Thomas Bragg, D.o, D.O
Family Medicine — Payments: $5,869
Family Medicine $5,869
Dr. Denise Freidel, D.o, D.O
Family Medicine — Payments: $5,809
Family Medicine $5,809
Katy Williams, M.d, M.D
Family Medicine — Payments: $4,062
Family Medicine $4,062